We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Study Shows Low Radiation Doses May Harm CV System

By HospiMedica International staff writers
Posted on 27 Jul 2017
The results of a new study indicate that even low levels of X-Rays can harm the human cardiovascular system.

The researchers found that even low doses of ionizing radiation, around 0.5 Gy, from recurring CT imaging scans for example are associated with a significantly higher risk of cardiovascular damage, even as long as decades after radiation exposure.

The study was published online in the July 11, 2017, issue of the International Journal of Radiation Biology by researchers at the Helmholtz Zentrum München, German Research Center for Environmental Health (Munich, Germany).

The researchers found several permanent alterations in human coronary artery endothelial cells as a result of a 0.5 Gy radiation dose that could negatively affect essential cell functions. More...
The radiation causes the cells to produce less nitric oxide, essential for a number of physiological processes in the cells, but more Reactive Oxygen Species (ROS) that can damage proteins and DNA. The researchers also found that the cells were aging prematurely, and are less able to degrade oxidised proteins.

The researchers found that in their cell cultures these changes occurred only after one or two weeks because these cells divide more slowly than others. This is equivalent call to cell division times of several years in a living organism. The study authors conclude that these molecular changes indicate long-term premature dysfunction and an increased risk of cardiovascular disease following exposure to relatively low radiation doses.

Related Links:
Helmholtz Zentrum München


Gold Member
12-Channel ECG
CM1200B
Gold Member
Blood Gas Analyzer
i-Check200
Glucose Meter
StatStrip®
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.